Vaccination rates among kindergarteners fall as exemptions rise to all-time high
The data, posted to the Centers for Disease Control and Prevention website Thursday, showed vaccination coverage among kindergartners during the 2024 to 2025 school year decreased for all reported vaccines from the year before.
According to the data, about 92.1% kindergartners got the diphtheria, tetanus and acellular pertussis vaccine (DTaP), and 92.5% received the measles, mumps and rubella vaccine (MMR) and polio vaccine — all down slightly from the previous school year.
These decreases come as the U.S. has recorded the most measles cases in more than 30 years. A large share of the infections were connected to a West Texas outbreak primarily affecting children and teenagers, nearly all of whom were unvaccinated or have an unknown vaccination status.
Experts say outbreaks like these are more likely when vaccination rates drop — and rates have already fallen below the 95% needed for herd immunity.
Exemptions among U.S. kindergartners also rose to an all-time high during the 2024 to 2025 school year, the data showed, increasing to 3.6% from 3.3% the year before.
Exemptions increased in 36 states and Washington, D.C., with 17 states reporting exemptions exceeding 5%, the CDC added.
Speaking on "CBS Mornings" earlier this year about the measles outbreak, Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, expressed worry over exemption increases across the country.
"We're really seeing a lot of exemptions [and] concerns about vaccination that are not warranted," she said, adding, for most people, the MMR vaccine will protect you for life against measles, one of the most contagious infectious diseases. Doctors and public health officials say the vaccine, which has been used for decades, is safe and highly effective.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
6 minutes ago
- Medscape
New Lyme Blood Test Bests Standard Diagnostics
A new blood test for Lyme disease outperforms standard diagnostic testing across all stages of the disease, according to new data presented at the 2025 Association for Diagnostics and Laboratory Medicine annual meeting in Chicago. The test, which pairs a multiplexed assay with a machine learning algorithm, showed over 90% accuracy in diagnosing Lyme disease in 308 human serum samples. The CDC estimates that about 476,000 individuals may be diagnosed and treated for Lyme disease each year in the US. The tick-borne disease, caused primarily by infection with Borrelia burgdorferi , is most treatable in the first few weeks of infection, but diagnosis during this early stage poses a challenge to clinicians. Barriers to Early Diagnosis The most common sign of early infection is a skin rash called erythema migrans (EM) that often occurs at the site of the tick bite. While a bull-eye-shaped rash is telltale sign of Lyme disease, this type of EM is actually not a common presentation, said Liz Horn, PhD, MBI, principal investigator of the Lyme Disease Biobank, a biorepository of samples from people with Lyme disease, headquartered in Portland, Oregon. She was not involved with the work. EMs can present in different forms, and about 30% of people with Lyme disease do not develop a rash. 'If you don't have a rash, you have to rely on serologic tests,' Horn said, which are notoriously insensitive in early disease, as antibodies can take weeks to develop. The CDC currently recommends a two-test format. Standard two-tier testing (STTT) involves an enzyme immunoassay as the first step, which, if positive or indeterminate, is followed by a Western Blot. In the first few weeks of disease, antibody levels can be too low to detect, leading to false negatives. In a recent study led by Horn using samples from individuals with signs and symptoms of early Lyme disease who were enrolled in the Lyme Disease Biobank, just 34% of patients presenting with EM > 5 cm tested positive on serologic tests. Among patients without EM, only 16% had positive results, and among those with EM ≤ 5 cm, the positivity rate dropped to just 5%. 'If we could get a serology test that works better in early disease, that could have great benefits for both patients and providers,' Horn said. Pairing AI With a Multiassay This new blood test, called LymeSeek, works differently by detecting 10 different antigens simultaneously. An algorithm developed using deep learning 'sorts through all of the responses,' explained Holly Ahern, MS, MT, the chief scientific officer of ACES Diagnostics, the company developing LymeSeek, in Paradise Valley, Arizona. 'That is what gives the test its very high sensitivity and specificity,' she said. Ahern is also an associate professor of microbiology at State University of New York at Adirondack (SUNY Adirondack) in Queensbury, New York. To validate the test, developers analyzed the human serum samples of 150 control individuals and 158 Lyme disease cases, across all phases of Lyme disease. Samples were provided by the Lyme Disease Biobank, the CDC, and the Johns Hopkins University Lyme Disease Research Center in Baltimore. The control samples were from patients in endemic and nonendemic areas and included individuals with non-Lyme look-like diseases, like mononucleosis and rheumatoid arthritis. The test correctly classified 281 samples as Lyme cases or control individuals, resulting in a test sensitivity of 91.7% and a specificity of 90.7%. In an additional analysis, the ACES diagnostics team also compared LymeSeek to STTT using samples from the Johns Hopkins Lyme Disease Research Center. In very early stages of disease (0-72 hours after appearance of an EM rash), LymeSeek diagnosed 100% of Lyme cases, whereas standard testing identified only 37% of cases. In samples taken 3-4 weeks after EM appearance, LymeSeek's results remained consistent, and standard testing identified 76% of cases. 'The observed seroconversion indicates the enrolled patients did have Lyme disease and is a confirmation that the test result given by LymeSeek is a true positive test result,' Ahern added. In patients with post-treatment Lyme disease (6 months or more after infection), LymeSeek identified 97% of cases, whereas standard testing identified less than half (46%). 'With this one single test, we can detect [Lyme] in the early stages, but we can also detect it across all stages of the disease' Ahern said, which includes through 1 year from first Lyme diagnosis. ACES Diagnostics is now working to develop a clinical trial plan with the FDA. The test has received a De Novo classification, meaning it's being evaluated on its own merits rather than compared to the current standard diagnostics. 'We're not just showing that we are as good as two-tier serology because what's the point of being as good as a test that really isn't very good?' Ahern said.
Yahoo
35 minutes ago
- Yahoo
Doctors fight vaccine mistrust as Romania hit by measles outbreak
When epidemiologist Daniela Gafita makes her rounds in the remote villages of northeastern Romania to educate communities about the risks of measles, she frequently encounters parents who hesitate to have their children vaccinated. With measles cases in Europe hitting a 25-year high last year, Romania was the country most affected: it recorded 13,000 of the approximately 18,000 cases registered between June 2024 and May 2025 in the European Economic Area, which includes EU members as well as Iceland, Liechtenstein and Norway. But the disease has also re-emerged globally, with the United States confronting its worst epidemic in 30 years, in part fuelled by anti-vaccine misinformation that has been circulating on social media since the Covid-19 pandemic. Despite widespread vaccine scepticism in Romania, Gafita and her colleagues from the local health department are undeterred in their mission to spread the immunisation message. "We are trying to recover little by little what we lost" in the past decades when the situation was still at bay, said the 52-year-old. Romania has the EU's lowest vaccination rate at 62 percent, a far cry from the 95 percent the World Health Organization (WHO) says is needed for effective control. - Irrational fear - But it's a fight on many fronts, due not only to poverty but also poor access to health care and persistent rumours that vaccination causes autism. "I heard the vaccine is dangerous," said a woman, who declined to give her name, in the village of Raucesti. Elena Armenia, who also lives in the village of 7,500 people, told AFP that she did not want her youngest child to be vaccinated after reading "about a link to autism" online, a misconception that has been refuted by the scientific community. "Fear crept into my mind and I can't shake it off," said the 34-year-old. Her neighbours' children recently ended up in hospital after contracting measles, a contagious disease that causes fever, respiratory symptoms and a rash -- but can also lead to pneumonia, brain inflammation and even death. Romania reported eight fatalities from measles between June 2024 to May 2025. In July, a child died in Britain, with three deaths being recorded in the United States this year. Family doctor Monica Apostol told AFP that she was less optimistic than some of her colleagues about Romania's vaccination rate being boosted soon. "I'm hitting a brick wall," she said about her many conversations with parents. - Far-right anti-vaxers - Several factors have contributed to lower vaccination rates and subsequently to the resurgence of measles in Romania, where jabs are offered for free but are not mandatory. Millions of Romanians, including many health professionals, left the country after the end of communism in 1989. Moreover, the country has seen periods of vaccine shortages, but also an underfunded healthcare system and an increasing lack of trust in authorities. During the Covid pandemic, public figures in Romania but also worldwide began launching or endorsing anti-vaccination campaigns, with US President Donald Trump appointing Robert F. Kennedy Jr as health secretary despite his support of anti-vaccine conspiracy theories. Romania's far right also seized on anger over strict pandemic measures and started promoting anti-vaccine beliefs. Far-right leader George Simion, who topped the first round of the presidential election in May before losing in the second round, has said that parents should have the freedom to decide whether to have their children vaccinated or not. Pro-European President Nicusor Dan recently called on authorities to redouble their efforts to "regain people's trust", and combat a deluge of conspiracy theories and fake news that has eroded confidence. "The recent elections have shown that misinformation campaigns are conducted in a highly professional manner," said Gindrovel Dumitra, coordinator for vaccinations at one of Romania's main doctors' associations. Faced with a situation that is "out of control", his colleague Gafita advocates for tougher nationwide rules, including the need for children to be vaccinated to be able to attend school. "Even if such measures are unpopular and contrary to what many people want," she said. ani/anb-kym/gv
Yahoo
11 hours ago
- Yahoo
Teenager and Toddler Contract Parasite Spread by Exposure to Raccoon Feces
The two unrelated children were hospitalized and treated for B. procyonis infectionsNEED TO KNOW Two California children contracted a rare parasite commonly spread by raccoon feces and occasionally by dogs The two unrelated kids — a teenager and a toddler — were hospitalized and treated for B. procyonis infections in 2024 The Centers for Disease Control and Prevention (CDC) says people should "avoid contact with raccoons and their feces"Two children in California contracted a rare parasite that is commonly spread by raccoon feces and occasionally by dogs. The Centers for Disease Control and Prevention (CDC) detailed two 2024 cases of a B. procyonis infection found in two unrelated children — a 14-year-old boy and a 15-month-old boy — in its latest Morbidity and Mortality Weekly Report, published on Thursday, July 31. The infection, commonly referred to as raccoon roundworm infection, is caused by the Baylisascaris procyonis roundworm, which is often spread by exposure to raccoon feces and can also be transmitted to dogs in rare cases. According to the report, the Los Angeles County Department of Public Health (LACDPH) was notified last year of two patients with neurological signs and symptoms — such as behavioral change, lethargy and "gait instability" — consistent with the infection. Both cases were in the South Bay area of Los Angeles County, according to a LACDPH release from September 2024. According to the CDC, raccoons can "shed millions of roundworm eggs in their feces every day," which then become infective after a few weeks and can develop into larvae when consumed by "nondefinitive hosts." There have only been 35 cases in humans reported in the U.S., the health organization said. The teenage boy, who is autistic, had a history of ingesting non-food items and was initially hospitalized in May 2024 due to a series of "behavioral changes," according to the new information from the CDC. After "enhancing" lesions were detected in the boy's brain, doctors discovered and treated what the CDC called "a live parasitic nematode" in his eye. The teen was prescribed medication for a six-week period, before symptoms "subsequently resolved" and he returned to his "baseline neurologic status," according to the agency. The second patient, a toddler, was also hospitalized that June, before a brain MRI found "diffuse white matter abnormalities." Months later, doctors eventually discovered a "live parasitic nematode" in his eye — which, like the older boy, was treated with a laser. Both boys were also treated with a drug for paramedic worms, albendazole and the anti-inflammatory corticosteroids. While a source of the infection was not clear for the toddler, the CDC reported that a raccoon latrine — or an area where the animals defecate — was located on the rooftop of the teenager's home, "directly above the entrance to the premises, allowing feces to roll onto the landing below." The child was suspected to have consumed the feces or feces-contaminated soil. Due to the extent that raccoons visit the home, and unsuccessful efforts to move the animal's latrine, the family is planning on moving, the CDC said. "Given the severity of disease in humans, the high prevalence of B. procyonis infection in raccoons, and the proximity of raccoons to humans and pets, B. procyonis is a substantial public health concern," the CDC said. "To prevent infection, the public should avoid contact with raccoons and their feces, not keep raccoons as pets, ensure that children or persons with developmental disabilities do not place contaminated objects or fingers into their mouths, practice good hand hygiene after outdoor activities and safely remove raccoon latrines on properties, paying special attention to flat surfaces such as rooftops, decks, tree stumps, or unsealed attics and other areas where raccoons prefer to defecate," they continued. Since dogs can also be infected, the CDC encourages dog owners to prevent their pets from eating raccoon feces and said pets should be treated with a "year-round parasite prevention product." Read the original article on People
